{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:09:52Z","timestamp":1789898992241,"version":"4.0.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/nrneurol.2016.75","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T09:35:39Z","timestamp":1464341739000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Skeletal muscle disorders of glycogenolysis and glycolysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Richard","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"BFnrneurol201675_CR1","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","volume":"13","author":"H Ozen","year":"2007","unstructured":"Ozen, H. Glycogen storage diseases: new perspectives. World J. Gastroenterol. 13, 2541\u20132553 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnrneurol201675_CR2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","volume":"9","author":"R-M Boustany","year":"2013","unstructured":"Boustany, R.-M. Lysosomal storage diseases \u2014 the horizon expands. Nat. Rev. Neurol. 9, 583\u2013598 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol201675_CR3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1079\/PNS2003281","volume":"62","author":"JA Levine","year":"2003","unstructured":"Levine, J. A. Non-exercise activity thermogenesis. Proc. Nutr. Soc. 62, 667\u2013679 (2003).","journal-title":"Proc. Nutr. Soc."},{"key":"BFnrneurol201675_CR4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","volume":"81","author":"R Quinlivan","year":"2010","unstructured":"Quinlivan, R. et al. McArdle disease: a clinical review. J. Neurol. Neurosurg. Psychiatry 81, 1182\u20131188 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201675_CR5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10545-014-9771-y","volume":"38","author":"N Preisler","year":"2015","unstructured":"Preisler, N., Haller, R. G. & Vissing, J. Exercise in muscle glycogen storage diseases. J. Inherit. Metab. Dis. 38, 551\u2013563 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnrneurol201675_CR6","first-page":"13","volume":"10","author":"B McArdle","year":"1951","unstructured":"McArdle, B. Myopathy due to a defect in muscle glycogen breakdown. Clin. Sci. 10, 13\u201335 (1951).","journal-title":"Clin. Sci."},{"key":"BFnrneurol201675_CR7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM199307223290404","volume":"329","author":"S Tsujino","year":"1993","unstructured":"Tsujino, S., Shanske, S. & DiMauro, S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease). N. Engl. J. Med. 329, 241\u2013245 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22806","volume":"36","author":"G Nogales-Gadea","year":"2015","unstructured":"Nogales-Gadea, G. et al. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum. Mutat. 36, 669\u2013678 (2015).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol201675_CR9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/gim.2015.9","volume":"17","author":"M DeCastro","year":"2015","unstructured":"DeCastro, M., Johnston, J. & Biesecker, L. Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data. Genet. Med. 17, 1002\u20131006 (2015).","journal-title":"Genet. Med."},{"key":"BFnrneurol201675_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","volume":"83","author":"A Lucia","year":"2012","unstructured":"Lucia, A. et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J. Neurol. Neurosurg. Psychiatry 83, 322\u2013328 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201675_CR11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","volume":"132","author":"J Vissing","year":"2009","unstructured":"Vissing, J., Duno, M., Schwartz, M. & Haller, R. G. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Brain 132, 1545\u20131552 (2009).","journal-title":"Brain"},{"key":"BFnrneurol201675_CR12","volume-title":"Essentials of Exercise Physiology","author":"WD McArdle","year":"2000","unstructured":"McArdle, W. D., Katch, F. I. & Katch, V. L. Essentials of Exercise Physiology 2nd edn (Lippincott Williams & Wilkins, 2000)."},{"key":"BFnrneurol201675_CR13","volume-title":"Muscle Biopsy: A Practical Approach","author":"V Dubowitz","year":"2013","unstructured":"Dubowitz, V., Sewry, A. & Oldfors, A. Muscle Biopsy: A Practical Approach 4th edn (Saunders Ltd, 2013)."},{"key":"BFnrneurol201675_CR14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nmd.2007.07.008","volume":"17","author":"M Cristina Pacheco","year":"2007","unstructured":"Cristina Pacheco, M., Miles, L. & Bove, K. E. False negative histochemical reaction for myophosphorylase activity in fulminant sepsis due to methicillin resistant Staphylococcus aureus. Neuromuscul. Disord. 17, 983\u2013985 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/173973a0","volume":"173","author":"H Huxley","year":"1954","unstructured":"Huxley, H. & Hanson, J. Changes in the cross-striations of muscle during contraction and stretch and their structural interpretation. Nature 173, 973\u2013976 (1954).","journal-title":"Nature"},{"key":"BFnrneurol201675_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/173971a0","volume":"173","author":"AF Huxley","year":"1954","unstructured":"Huxley, A. F. & Neidergerke, R. Structural changes in muscle during contraction; interference microscopy of living muscle fibres. Nature 173, 971\u2013973 (1954).","journal-title":"Nature"},{"key":"BFnrneurol201675_CR17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","volume":"30","author":"CM Pearson","year":"1961","unstructured":"Pearson, C. M., Rimer, D. G. & Mommaerts, W. F. A metabolic myopathy due to absence of muscle phosphorylase. Am. J. Med. 30, 502\u2013517 (1961).","journal-title":"Am. J. Med."},{"key":"BFnrneurol201675_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.10725","volume":"54","author":"J Vissing","year":"2003","unstructured":"Vissing, J. & Haller, R. G. A diagnostic cycle test for McArdle's disease. Ann. Neurol. 54, 539\u2013542 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201675_CR19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00005768-200004000-00008","volume":"32","author":"LB Gladden","year":"2000","unstructured":"Gladden, L. B. Muscle as a consumer of lactate. Med. Sci. Sports Exerc. 32, 764\u2013771 (2000).","journal-title":"Med. Sci. Sports Exerc."},{"key":"BFnrneurol201675_CR20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00005768-200004000-00009","volume":"32","author":"CM Donovan","year":"2000","unstructured":"Donovan, C. M. & Pagliassotti, M. J. Quantitative assessment of pathways for lactate disposal in skeletal muscle fiber types. Med. Sci. Sports Exerc. 32, 772\u2013777 (2000).","journal-title":"Med. Sci. Sports Exerc."},{"key":"BFnrneurol201675_CR21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.31.3.268","volume":"31","author":"R Gruener","year":"1968","unstructured":"Gruener, R., McArdle, B., Ryman, B. E. & Weller, R. O. Contracture of phosphorylase deficient muscle. J. Neurol. Neurosurg. Psychiatry 31, 268\u2013283 (1968).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201675_CR22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1080\/02640414.2014.906045","volume":"32","author":"JP Buckley","year":"2014","unstructured":"Buckley, J. P., Quinlivan, R. M., Sim, J., Eston, R. G. & Short, D. S. Heart rate and perceived pain responses to a functional walking test in McArdle disease. J. Sports Sci. 32, 1561\u20131569 (2014).","journal-title":"J. Sports Sci."},{"key":"BFnrneurol201675_CR23","volume-title":"Borg's Perceived Exertion and Pain Scales","author":"G Borg","year":"1998","unstructured":"Borg, G. Borg's Perceived Exertion and Pain Scales (Human Kinetics, 1998)."},{"key":"BFnrneurol201675_CR24","unstructured":"Department of Health. Start active, stay active: report on physical activity in the UK. GOV. UK https:\/\/www.gov.uk\/government\/publications\/start-active-stay-active-a-report-on-physical-activity-from-the-four-home-countries-chief-medical-officers (2011)."},{"key":"BFnrneurol201675_CR25","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","volume":"43","author":"CE Garber","year":"2011","unstructured":"Garber, C. E. et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med. Sci. Sports Exerc. 43, 1334\u20131359 (2011).","journal-title":"Med. Sci. Sports Exerc."},{"key":"BFnrneurol201675_CR26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.1989.03430170057028","volume":"262","author":"SN Blair","year":"1989","unstructured":"Blair, S. N. et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262, 2395\u20132401 (1989).","journal-title":"JAMA"},{"key":"BFnrneurol201675_CR27","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama, S. et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301, 2024\u20132035 (2009).","journal-title":"JAMA"},{"key":"BFnrneurol201675_CR28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.CIR.0000024413.15949.ED","volume":"106","author":"T Kavanagh","year":"2002","unstructured":"Kavanagh, T. et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 106, 666\u2013671 (2002).","journal-title":"Circulation"},{"key":"BFnrneurol201675_CR29","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2003.07.028","volume":"42","author":"T Kavanagh","year":"2003","unstructured":"Kavanagh, T. et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J. Am. Coll. Cardiol. 42, 2139\u20132143 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneurol201675_CR30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","volume":"346","author":"J Myers","year":"2002","unstructured":"Myers, J., Prakash, M., Froelicher, V., Partington, S. & Atwood, J. E. Exercise capacity and mortality among men referred for exercise testing. N. Engl. J. Med. 346, 793\u2013801 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6823-9-3","volume":"9","author":"JA Babraj","year":"2009","unstructured":"Babraj, J. A. et al. Extremely short duration high intensity interval training substantially improves insulin action in young males. BMC Endocr. Disord. 9, 3 (2009).","journal-title":"BMC Endocr. Disord."},{"key":"BFnrneurol201675_CR32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00125-009-1354-3","volume":"52","author":"D Hansen","year":"2009","unstructured":"Hansen, D. et al. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise at lowering blood HbA1c in obese type 2 diabetes patients. Diabetologia 52, 1789\u20131797 (2009).","journal-title":"Diabetologia"},{"key":"BFnrneurol201675_CR33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1519\/JSC.0b013e318198fd28","volume":"23","author":"DI Musa","year":"2009","unstructured":"Musa, D. I., Adeniran, S. A., Dikko, A. U. & Sayers, S. P. The effect of a high-intensity interval training program on high-density lipoprotein cholesterol in young men. J. Strength Cond. Res. 23, 587\u2013592 (2009).","journal-title":"J. Strength Cond. Res."},{"key":"BFnrneurol201675_CR34","doi-asserted-by":"crossref","first-page":"E851","DOI":"10.1152\/ajpendo.90545.2008","volume":"295","author":"YE Tsekouras","year":"2008","unstructured":"Tsekouras, Y. E. et al. High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men. Am. J. Physiol. Endocrinol. Metab. 295, E851\u2013E858 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneurol201675_CR35","doi-asserted-by":"crossref","first-page":"R1970","DOI":"10.1152\/ajpregu.00503.2006","volume":"292","author":"KA Burgomaster","year":"2007","unstructured":"Burgomaster, K. A. et al. Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R1970\u2013R1976 (2007).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneurol201675_CR36","doi-asserted-by":"crossref","first-page":"E180","DOI":"10.1152\/ajpendo.00073.2010","volume":"299","author":"JL Talanian","year":"2010","unstructured":"Talanian, J. L. et al. Exercise training increases sarcolemmal and mitochondrial fatty acid transport proteins in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 299, E180\u2013E188 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneurol201675_CR37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1249\/MSS.0000000000000458","volume":"47","author":"D Mungu\u00eda-Izquierdo","year":"2015","unstructured":"Mungu\u00eda-Izquierdo, D., Santalla, A. & Lucia, A. Cardiorespiratory fitness, physical activity and quality of life in patients with McArdle disease. Med. Sci. Sports Exerc. 47, 799\u2013808 (2015).","journal-title":"Med. Sci. Sports Exerc."},{"key":"BFnrneurol201675_CR38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","volume":"59","author":"RG Haller","year":"2006","unstructured":"Haller, R. G., Wyrick, P., Taivassalo, T. & Vissing, J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann. Neurol. 59, 922\u2013928 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201675_CR39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/0883073812451328","volume":"28","author":"S Garc\u00eda-Ben\u00edtez","year":"2013","unstructured":"Garc\u00eda-Ben\u00edtez, S., Fleck, S. J., Naclerio, F., Mart\u00edn, M. A. & Lucia, A. Resistance (weight lifting) training in an adolescent with McArdle disease. J. Child Neurol. 28, 805\u2013808 (2013).","journal-title":"J. Child Neurol."},{"key":"BFnrneurol201675_CR40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnagi.2014.00334","volume":"6","author":"A Santalla","year":"2014","unstructured":"Santalla, A. et al. Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits. Front. Aging Neurosci. 6, 334 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"BFnrneurol201675_CR41","first-page":"CD004760","volume":"6","author":"RA Kley","year":"2013","unstructured":"Kley, R. A., Tarnopolsky, M. A. & Vorgerd, M. Creatine for treating muscle disorders. Cochrane Database Syst. Rev. 6, CD004760 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrneurol201675_CR42","first-page":"CD003458","volume":"11","author":"R Quinlivan","year":"2014","unstructured":"Quinlivan, R., Martinuzzi, A. & Schoser, B. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Cochrane Database Syst. Rev. 11, CD003458 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrneurol201675_CR43","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","volume":"349","author":"J Vissing","year":"2003","unstructured":"Vissing, J. & Haller, R. G. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N. Engl. J. Med. 349, 2503\u20132509 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncpneuro0913","volume":"4","author":"A Lucia","year":"2008","unstructured":"Lucia, A. et al. McArdle disease: what do neurologists need to know? Nat. Clin. Pract. Neurol. 4, 568\u2013577 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol201675_CR45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archneur.65.6.786","volume":"65","author":"ST Andersen","year":"2008","unstructured":"Andersen, S. T., Haller, R. G. & Vissing, J. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch. Neurol. 65, 786\u2013789 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201675_CR46","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.wnl.0000343002.74480.e4","volume":"72","author":"MC \u00d8rngreen","year":"2009","unstructured":"\u00d8rngreen, M. C. et al. Fat metabolism during exercise in patients with McArdle disease. Neurology 72, 718\u2013724 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol201675_CR47","first-page":"61","volume":"26","author":"M Vorgerd","year":"2007","unstructured":"Vorgerd, M. & Zange, J. Treatment of glycogenosis type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle. Acta Myol. 26, 61\u201363 (2007).","journal-title":"Acta Myol."},{"key":"BFnrneurol201675_CR48","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/brain\/aws141","volume":"135","author":"G Nogales-Gadea","year":"2012","unstructured":"Nogales-Gadea, G. et al. Knock-in mice for R50X mutation in the PYGM gene present with McArdle disease. Brain 135, 2048\u20132057 (2012).","journal-title":"Brain"},{"key":"BFnrneurol201675_CR49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2013.10.003","volume":"24","author":"JM Howell","year":"2014","unstructured":"Howell, J. M. et al. Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease. Neuromuscul. Disord. 24, 167\u2013177 (2014).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2014.10.002","volume":"25","author":"JM Howell","year":"2015","unstructured":"Howell, J. M., Dunton, E., Creed, K. E., Quinlivan, R. & Sewry, C. Investigating sodium valproate as a treatment for McArdle disease in sheep. Neuromuscul. Disord. 25, 111\u2013119 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI118799","volume":"98","author":"J Shen","year":"1996","unstructured":"Shen, J. et al. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J. Clin. Invest. 98, 352\u2013357 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol201675_CR52","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10038-006-0045-x","volume":"51","author":"Y Endo","year":"2006","unstructured":"Endo, Y. et al. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J. Hum. Genet. 51, 958\u2013963 (2006).","journal-title":"J. Hum. Genet."},{"key":"BFnrneurol201675_CR53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1432-1033.1967.tb00134.x","volume":"2","author":"F Van Hoof","year":"1967","unstructured":"Van Hoof, F. & Hers, H. G. The subgroups of type III glycogenosis. Eur. J. Biochem. 2, 265\u2013270 (1967).","journal-title":"Eur. J. Biochem."},{"key":"BFnrneurol201675_CR54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3476(05)81652-X","volume":"116","author":"J-H Ding","year":"1990","unstructured":"Ding, J.-H., de Barsy, T., Brown, B. I., Coleman, R. A. & Chen, Y.-T. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J. Pediatr. 116, 95\u2013100 (1990).","journal-title":"J. Pediatr."},{"key":"BFnrneurol201675_CR55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"Kishnani, P. S. et al. Glycogen storage disease type III diagnosis and management guidelines. Genet. Med. 12, 446\u2013463 (2010).","journal-title":"Genet. Med."},{"key":"BFnrneurol201675_CR56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2013.02.008","volume":"109","author":"N Preisler","year":"2013","unstructured":"Preisler, N. et al. Exercise intolerance in glycogen storage disease type III: weakness or energy deficiency. Mol. Genet. Metab. 109, 14\u201320 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneurol201675_CR57","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1212\/WNL.0000000000001518","volume":"84","author":"N Preisler","year":"2015","unstructured":"Preisler, N. et al. Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type III. Neurology 84, 1767\u20131771 (2015).","journal-title":"Neurology"},{"key":"BFnrneurol201675_CR58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2010.06.011","volume":"20","author":"C Wary","year":"2010","unstructured":"Wary, C. et al. Investigating glycogenosis type III with multi-parametric functional NMR imaging and spectroscopy. Neuromuscul. Disord. 20, 548\u2013558 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0006-291X(65)90156-7","volume":"19","author":"S Tarui","year":"1965","unstructured":"Tarui, S. et al. Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem. Biophys. Res. Commun. 19, 517\u2013523 (1965).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol201675_CR60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1073\/pnas.77.1.62","volume":"77","author":"S Vora","year":"1980","unstructured":"Vora, S., Seaman, C., Durham, S. & Piomelli, S. Isoenzymes of human phosphofructokinase: identification and subunit structural characterization of a new system. Proc. Natl Acad. Sci. USA 77, 62\u201366 (1980).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201675_CR61","first-page":"105","volume":"26","author":"A Toscano","year":"2007","unstructured":"Toscano, A. & Musumeci, O. Tarui disease and distal glycogenosis: clinical and genetic update. Acta Myol. 26, 105\u2013107 (2007).","journal-title":"Acta Myol."},{"key":"BFnrneurol201675_CR62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2796.2001.00780.x","volume":"240","author":"G Ronquist","year":"2001","unstructured":"Ronquist, G., Rudolphi, O., Engstr\u00f6m, I. & Waldenstr\u00f6m, A. Familial phosphofructokinase deficiency is associated with a disturbed calcium homeostasis in erythrocytes. J. Intern. Med. 240, 85\u201395 (2001).","journal-title":"J. Intern. Med."},{"key":"BFnrneurol201675_CR63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.siny.2011.04.010","volume":"16","author":"S DiMauro","year":"2011","unstructured":"DiMauro, S. & Garone, C. Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the respiratory chain. Semin. Fetal Neonatal Med. 16, 181\u2013189 (2011).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"BFnrneurol201675_CR64","first-page":"305","volume":"55","author":"JB Sherman","year":"1994","unstructured":"Sherman, J. B. et al. Common mutations in the phosphofructokinase-M gene Ashkenazi Jewish patients with glycogenesis VII \u2014 and their population frequency. Am. J. Hum. Genet. 55, 305\u2013313 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201675_CR65","doi-asserted-by":"crossref","first-page":"20070","DOI":"10.1074\/jbc.271.33.20070","volume":"27","author":"BF Smith","year":"1996","unstructured":"Smith, B. F. et al. Molecular basis of canine muscle type phosphofructokinase deficiency. J. Biol. Chem. 27, 20070\u201320074 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol201675_CR66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1196-337","volume":"14","author":"AJ Maichele","year":"1996","unstructured":"Maichele, A. J., Burwinkel, B., Maire, I., S\u00f8vik, O. & Kilimann, M. W. Mutations in the testis\/liver isoform of the phosphorylase kinase \u03b3 subunit (PHKG2) cause autosomal liver glycogenosis in gsd rat and in humans. Nat. Genet. 14, 337\u2013340 (1996).","journal-title":"Nat. Genet."},{"key":"BFnrneurol201675_CR67","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.153.3743.1534","volume":"153","author":"G Hug","year":"1966","unstructured":"Hug, G., Schubert, W. K. & Chuck, G. Phosphorylase kinase of the liver: deficiency in a girl with increased hepatic glycogen. Science 153, 1534\u20131535 (1966).","journal-title":"Science"},{"key":"BFnrneurol201675_CR68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","volume":"92","author":"NJ Beauchamp","year":"2007","unstructured":"Beauchamp, N. J. et al. Glycogen storage disease type IX: high variability in clinical phenotype. Mol. Genet. Metab. 92, 88\u201399 (2007).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneurol201675_CR69","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","volume":"190","author":"MF Lyon","year":"1961","unstructured":"Lyon, M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372\u2013373 (1961).","journal-title":"Nature"},{"key":"BFnrneurol201675_CR70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","volume":"111","author":"DS Bali","year":"2014","unstructured":"Bali, D. S. et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol. Genet. Metab. 111, 309\u2013313 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneurol201675_CR71","volume-title":"The Online Metabolic and Molecular Bases of Inherited Disease","author":"Y-T Chen","year":"2009","unstructured":"Chen, Y.-T. Kishnani, P. S. & Koeberl, D. Glycogen storage diseases. The Online Metabolic and Molecular Bases of Inherited Disease http:\/\/ommbid.mhmedical.com\/content.aspx?bookid=971&sectionid=62672129 (2009)."},{"key":"BFnrneurol201675_CR72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.1095","volume":"50","author":"GP Comi","year":"2001","unstructured":"Comi, G. P. et al. \u03b2-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann. Neurol. 50, 202\u2013207 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201675_CR73","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s00415-014-7512-7","volume":"261","author":"O Musumeci","year":"2014","unstructured":"Musumeci, O. et al. Recurrent rhabdomyolysis due to muscle \u03b2-enolase deficiency: very rare or underestimated. J. Neurol. 261, 2424\u20132428 (2014).","journal-title":"J. Neurol."},{"key":"BFnrneurol201675_CR74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1469-1809.1976.tb00131.x","volume":"39","author":"S-H Chen","year":"1976","unstructured":"Chen, S.-H. & Giblett, E. R. Enolase: human tissue distribution and evidence for three different loci. Ann. Hum. Genet. 39, 277\u2013280 (1976).","journal-title":"Ann. Hum. Genet."},{"key":"BFnrneurol201675_CR75","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","volume":"361","author":"T Stojkovic","year":"2009","unstructured":"Stojkovic, T. et al. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N. Engl. J. Med. 361, 425\u2013427 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","volume":"370","author":"LC Tegtmeyer","year":"2014","unstructured":"Tegtmeyer, L. C. et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N. Engl. J. Med. 370, 533\u2013542 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2014.06.002","volume":"112","author":"E Morava","year":"2014","unstructured":"Morava, E. Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG. Mol. Genet. Metab. 112, 275\u2013279 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrneurol201675_CR78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mus.23527","volume":"47","author":"J Salameh","year":"2013","unstructured":"Salameh, J., Goyal, N., Choudry, R., Camelo-Piragua, S. & Chong, P. S. Phosphoglycerate mutase deficiency with tubular aggregates in a patient from Panama. Muscle Nerve 47, 138\u2013140 (2013).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201675_CR79","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/mus.20622","volume":"34","author":"SJ Oh","year":"2006","unstructured":"Oh, S. J. et al. Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency. Muscle Nerve 34, 572\u2013576 (2006).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201675_CR80","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/mus.880181412","volume":"3","author":"S Tsujino","year":"1995","unstructured":"Tsujino, S., Shanske, S., Sakoda, S., Toscano, A. & DiMauro, S. Molecular genetic studies in muscle phosphoglycerate mutase (PGAM-M) deficiency. Muscle Nerve Suppl. 3, S50\u2013S53 (1995).","journal-title":"Muscle Nerve Suppl."},{"key":"BFnrneurol201675_CR81","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2009.08.007","volume":"19","author":"P Tonin","year":"2009","unstructured":"Tonin, P. et al. Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene. Neuromuscul. Disord. 19, 776\u2013778 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/beha.1999.0062","volume":"13","author":"H Fujii","year":"2000","unstructured":"Fujii, H. & Miwa, S. Other erythrocyte enzyme deficiencies associated with non-haematological symptoms: phosphoglycerate kinase and phosphofructokinase deficiency. Baillieres Best Pract. Res. Clin. Haematol. 13, 141\u2013148 (2000).","journal-title":"Baillieres Best Pract. Res. Clin. Haematol."},{"key":"BFnrneurol201675_CR83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nmd.2008.12.004","volume":"19","author":"R Spiegel","year":"2009","unstructured":"Spiegel, R. et al. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromuscul. Disord. 19, 207\u2013211 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/mus.21612","volume":"41","author":"E Sotiriou","year":"2010","unstructured":"Sotiriou, E., Greene, P., Krishna, S., Hirano, M. & DiMauro, S. Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle Nerve 41, 707\u2013710 (2010).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201675_CR85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12185-014-1615-x","volume":"100","author":"M Tamai","year":"2014","unstructured":"Tamai, M. et al. Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy. Int. J. Hematol. 100, 393\u2013397 (2014).","journal-title":"Int. J. Hematol."},{"key":"BFnrneurol201675_CR86","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2169\/internalmedicine.34.502","volume":"34","author":"H Miyajima","year":"1995","unstructured":"Miyajima, H., Takahashi, Y. & Kaneko, E. Characterization of the oxidative metabolism in lactate dehydrogenase A deficiency. Intern. Med. 34, 502\u2013506 (1995).","journal-title":"Intern. Med."},{"key":"BFnrneurol201675_CR87","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/mus.880181413","volume":"3","author":"T Kanno","year":"1995","unstructured":"Kanno, T. & Maekawa, M. Lactate dehydrogenase M-subunit deficiencies: clinical features, metabolic background, and genetic heterogeneities. Muscle Nerve Suppl. 3, S54\u2013S60 (1995).","journal-title":"Muscle Nerve Suppl."},{"key":"BFnrneurol201675_CR88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s100380050111","volume":"44","author":"K Hidaka","year":"1999","unstructured":"Hidaka, K. et al. First case of missense mutation (LDH-H:R171P) in exon 4 of the lactate dehydrogenase gene detected in a Japanese patient. J. Hum. Genet. 44, 69\u201372 (1999).","journal-title":"J. Hum. Genet."},{"key":"BFnrneurol201675_CR89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2015.10.012","volume":"26","author":"H Akman","year":"2016","unstructured":"Akman, H. et al. Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1. Neuromuscul. Disord. 26, 16\u201320 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR90","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nmd.2011.08.008","volume":"22","author":"S Sukigara","year":"2012","unstructured":"Sukigara, S. et al. Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia. Neuromuscul. Disord. 22, 162\u2013165 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201675_CR91","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ana.24284","volume":"76","author":"E Malfatti","year":"2014","unstructured":"Malfatti, E. et al. A new muscle glycogen storage disease associated with glycogenin-1 deficiency. Ann. Neurol. 76, 891\u2013898 (2014).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201675_CR92","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ana.23963","volume":"74","author":"J Nilsson","year":"2013","unstructured":"Nilsson, J. et al. Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1. Ann. Neurol. 74, 914\u2013919 (2013).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201675_CR93","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","volume":"11","author":"G Kollberg","year":"2007","unstructured":"Kollberg, G. et al. Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0. N. Engl. J. Med. 11, 1507\u20131514 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201675_CR94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mam.2015.08.006","volume":"46","author":"C Hedberg-Oldfors","year":"2015","unstructured":"Hedberg-Oldfors, C. & Oldfors, A. Polyglucosan storage myopathies. Mol. Aspects Med. 46, 85\u2013100 (2015).","journal-title":"Mol. Aspects Med."},{"key":"BFnrneurol201675_CR95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.nmd.2015.05.009","volume":"25","author":"R Quinlivan","year":"2015","unstructured":"Quinlivan, R. et al. Report on the EUROMAC McArdle testing exercise workshop. Madrid, Spain, 11\u201312 July 2014. Neuromuscul. Disord. 25, 739\u2013745 (2015).","journal-title":"Neuromuscul. Disord."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.75","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2016.75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:20:19Z","timestamp":1684470019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2016.75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFnrneurol201675"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2016.75","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]},"assertion":[{"value":"27 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}